3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
12
Sarcoma
3
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Advanced Non CNS Tumors
1
Adenocarcinoma
1
Interventions
mirdametinib
2
tipifarnib
1
peginterferon alfa-2b
1
nilotinib
1
binimetinib
1
Vincristine
1
Temozolomide
1
Radiosurgery
1
Imatinib Mesylate
1
Everolimus
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurofibroma
×
talimogene laherparepvec
×
Clear all
No trials found.